Siemens Healthineers to Acquire Varian for $16.4B

Share this

Siemens Healthineers to Acquire Varian for $16.4B


  • Siemens Healthineers to acquire Varian in an all-cash transaction- at a price of $177.50/ share with 42% to the 30-day volume-weighted average closing price of Varian's common stock as of July 31- 2020- making a total deal value ~$16.4B
  • The transaction is expected to be closed in H1’21. The combined company will offer an integrated platform of end-to-end oncology solutions to addressing the complete continuum of cancer care- from screening and diagnosis to care delivery and post-treatment survivorship
  • Varian and Siemens Healthineers will lead the digital transformation of oncology healthcare- enabling more efficient diagnosis- increased treatment quality and access- personalized precision cancer care- and improved outcomes for millions of patients worldwide

­ Ref: Varian | Image: Varian

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions